Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Epidemiologic and economic effect of methicillin-resistant Staphylococcus aureus in obstetrics.

Beigi RH, Bunge K, Song Y, Lee BY.

Obstet Gynecol. 2009 May;113(5):983-91. doi: 10.1097/AOG.0b013e3181a116e4.

PMID:
19384112
2.

[On the economic burden of MRSA in Germany].

Claus F, Sachse A, Ried W.

Gesundheitswesen. 2014 Dec;76(12):800-6. doi: 10.1055/s-0034-1381987. Epub 2014 Nov 5. Review. German.

PMID:
25372655
3.

Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.

Gould IM, Reilly J, Bunyan D, Walker A.

Clin Microbiol Infect. 2010 Dec;16(12):1721-8. doi: 10.1111/j.1469-0691.2010.03365.x. Epub 2010 Nov 5. Review.

4.

Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review.

Farbman L, Avni T, Rubinovitch B, Leibovici L, Paul M.

Clin Microbiol Infect. 2013 Dec;19(12):E582-93. doi: 10.1111/1469-0691.12280. Epub 2013 Aug 28. Review.

5.

Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting.

Kang J, Mandsager P, Biddle AK, Weber DJ.

Infect Control Hosp Epidemiol. 2012 May;33(5):477-86. doi: 10.1086/665315. Epub 2012 Mar 21. Review.

PMID:
22476274
6.

A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.

Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.

Health Technol Assess. 2008 Jan;12(1):iii-iv, xi-xii, 1-147. Review.

7.

Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.

Bounthavong M, Hsu DI, Okamoto MP.

Int J Clin Pract. 2009 Mar;63(3):376-86. doi: 10.1111/j.1742-1241.2008.01958.x. Review.

PMID:
19222624
8.

Methicillin-resistant Staphylococcus aureus in obstetrics.

Sheffield JS.

Am J Perinatol. 2013 Feb;30(2):125-9. doi: 10.1055/s-0032-1333134. Epub 2013 Jan 4. Review.

PMID:
23292915
9.
10.

Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW.

Euro Surveill. 2010 Oct 14;15(41):19688. Review. Erratum in: Euro Surveill. 2010;15(42). pii: 19694.

11.

Update: Methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery.

Tom TS, Kruse MW, Reichman RT.

Ann Thorac Surg. 2009 Aug;88(2):695-702. doi: 10.1016/j.athoracsur.2009.02.010. Review.

PMID:
19632455
12.

Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Tübbicke A, Hübner C, Kramer A, Hübner NO, Fleßa S.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2497-511. Epub 2012 May 10. Review.

PMID:
22573360
13.

Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.

Gould IM.

Int J Antimicrob Agents. 2006 Nov;28(5):379-84. Epub 2006 Oct 11. Review.

PMID:
17045462
14.
15.

Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus?

Lucet JC, Regnier B.

Clin Infect Dis. 2010 Sep 1;51(5):585-90. doi: 10.1086/655695. Review.

PMID:
20662715
16.

Methicillin-resistant Staphylococcus aureus infection in the obstetric setting.

Kriebs JM.

J Midwifery Womens Health. 2008 May-Jun;53(3):247-50. doi: 10.1016/j.jmwh.2008.02.001. Review.

PMID:
18455099

Supplemental Content

Support Center